GlassScriptPhysician profile
Marcus A Cox
NPI 1538681945
$26,510.77
in general payments reported to CMS, 2019-2025
34 companies · $4,494 in 2025
The $4,494 reported for 2025 was more than what 81% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $129 · 2023: $18K · 2024: $3,836 · 2025: $4,494.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $17K · Food and Beverage: $6,799 · Travel and Lodging: $2,438 · Education: $146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $17,000.00 |
| Food and Beverage | $6,798.59 |
| Travel and Lodging | $2,437.50 |
| Education | $145.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $10,783.31 | 2023-2025 | Esprit, Supera, Ensite |
| Medtronic, INC. | $8,082.04 | 2023-2024 | Symplicity G3 |
| Penumbra, INC. | $1,954.70 | 2023-2025 | Indigo System, Penumbra System |
| Abiomed | $681.33 | 2024-2025 | Impella |
| Angiodynamics, INC. | $663.77 | 2023-2025 | Auryon Laser System 100-120 Vac, Alphavac |
| Boston Scientific Corporation | $560.19 | 2023-2025 | Avvigo Guidance System, Stingray, Comet |
| Shockwave Medical, INC | $489.49 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $471.94 | 2023-2025 | Lifevest |
| Terumo Medical Corporation | $400.82 | 2025 | Glidesheath Slender, R2p Misago, Glidewire |
| Novo Nordisk INC | $318.12 | 2024-2025 | Ozempic, Wegovy, Rybelsus |
| Amgen INC. | $250.55 | 2022-2025 | Repatha, Repatha |
| Edwards Lifesciences Corporation | $217.02 | 2024 | Sapien 3 Ultra Resilia |
| W. L. Gore & Associates, INC. | $166.53 | 2023 | Gore Cardioform Septal Occluder |
| Novartis Pharmaceuticals Corporation | $160.17 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $159.00 | 2023-2024 | Opsumit, Xarelto, Uptravi |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $152.00 | 2025 | Venclose Maven Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.88 | 2024 | Jardiance |
| Kestra Medical Technology Services, INC. | $118.87 | 2025 | Assure Wcd |
| Cagent Vascular INC | $74.90 | 2025 | Serrantor |
| Stryker Corporation | $73.84 | 2025 | Artix Mt, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Biosense Webster, INC. | $72.61 | 2023-2024 | Carto 3, Soundstar, Na |
| Chiesi USA, INC. | $72.00 | 2023 | Kengreal |
| E.R. Squibb & Sons, L.L.C. | $69.10 | 2023-2025 | Camzyos |
| Surmodics, INC. | $66.69 | 2024 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Venous Thrombectomy System, Sublime Microcatheter, 018, 200cm, Straight |
| Cardiva Medical, INC. | $54.57 | 2023-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Pfizer INC. | $52.45 | 2023-2024 | |
| Inari Medical, INC. | $52.20 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Inspire Medical Systems, INC. | $35.77 | 2025 | Inspire |
| Glaxosmithkline, LLC. | $31.37 | 2022-2025 | Arexvy, Shingrix |
| Merck Sharp & Dohme LLC | $29.75 | 2025 | Verquvo |
| Canon Medical Systems USA, INC. | $23.62 | 2024 | Interventional Angiography System |
| Scpharmaceuticals INC. | $16.70 | 2025 | |
| Lilly USA, LLC | $16.36 | 2025 | Zepbound, Mounjaro |
| Philips North America LLC | $14.11 | 2025 | Labosys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcus Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.